Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia
NCT ID: NCT04738396
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2020-12-29
2022-12-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Bundle Branch Pacing Versus Biventricular Pacing for Cardiac Resynchronization Therapy
NCT04110431
Application of Right Atrial Left Ventricular Fusion Pacing in Patients With CRT Indications
NCT03071978
Clinical Study of LBBP
NCT04919447
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
NCT05572957
Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D
NCT06745778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
LBBAP (left bundle branch area pacing) can generate a relatively narrow QRSd and fast left ventricular activation. As AV interval is an important pacing parameter relevant to cardiac function. This study is to investigate the cardiac electrical and mechanical function during LBBAP with different AV intervals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are willing to provide Informed Consent
* Patients who received LBBAP for at least 3 months
* Patients' implanted device can provide intracardiac electrograms
* Bradycardia patients with AVB or heart failure patients with LBBB
Exclusion Criteria
* Patients with persistent AF
* Patients who have medical conditions that would limit study participation
* Patients who were already enrolled in other clinical trial which would impact his/her participation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaohong Zhou
Role: STUDY_DIRECTOR
Medtronic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fuwai Hospital
Beijing, Beijing Municipality, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Zhejiang Greentown Cardiovascular Hospital
Hangzhou, Zhejiang, China
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
aLBBAP study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.